Peripheral blood haplo-SCT feasible for leukemia patients 70 years and older

by Elana GotkineFor patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative co

Updated on: December 28,2023

Peripheral blood haplo-SCT feasible for leukemia patients 70 years and older

by Elana GotkineFor patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative co

Updated on:December 28,2023

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

Updated on: December 20,2023

A case for routine evaluation of HER2 expression in ductal carcinoma in situ

by Impact JournalsCredit: Unsplash/CC0 Public DomainA new editorial paper was published inOncoscienceand is titled "HER2 expression should be routinely evaluated in DCIS to avoid unde

Updated on:December 20,2023

Recent screening rose among people under 50 after release of new colorectal guidelines

byAmerican Cancer SocietyCredit: CC0 Public DomainRecent colorectal cancer screening rates more than doubled among people ages 45 to 49 in the months after the release of updated American Cancer

Updated on: December 22,2023

Recent screening rose among people under 50 after release of new colorectal guidelines

byAmerican Cancer SocietyCredit: CC0 Public DomainRecent colorectal cancer screening rates more than doubled among people ages 45 to 49 in the months after the release of updated American Cancer

Updated on:December 22,2023

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on: November 14,2024

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on:November 14,2024

Generation X, millennials in US have higher risk of developing 17 cancers compared to older generations

byAmerican Cancer SocietyA new large study led by researchers at the American Cancer Societysuggests incidence rates continued to rise in successively younger generations in 17 of the 34 cancer

Updated on: August 27,2024

Generation X, millennials in US have higher risk of developing 17 cancers compared to older generations

byAmerican Cancer SocietyA new large study led by researchers at the American Cancer Societysuggests incidence rates continued to rise in successively younger generations in 17 of the 34 cancer

Updated on:August 27,2024

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on: July 17,2024

Comparison of FDG-PET/CT and CT for treatment evaluation of patients with unresectable malignant pleural mesothelioma

by Impact Journals LLCEpithelioid MPM, stage IIIB (cT4N0M0), woman, 64 years old. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28594A new research paper titled "Comparison of FDG

Updated on:July 17,2024

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on: December 22,2023

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on:December 22,2023

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was

Updated on: January 04,2024

Inhibition of prmt5 by repurposing market drugs: A fresh therapeutic pathway for cancer treatment

by TranSpreadDevelopment of AlphaLISA HTS screen to identify specific PRMT5 inhibitors. (A) Principle of AlphaLISA technique adapted to HTS. Biotinylated histone H4 (a well-known PRMT5 substrate) was

Updated on:January 04,2024

Precision physical activity prescriptions improve survival in colon cancer

by Pennington Biomedical Research CenterCredit: Unsplash/CC0 Public DomainPhysical activity may be associated with improved outcomes for patients undergoing postoperative treatment for Stage III colon

Updated on: December 26,2023

Precision physical activity prescriptions improve survival in colon cancer

by Pennington Biomedical Research CenterCredit: Unsplash/CC0 Public DomainPhysical activity may be associated with improved outcomes for patients undergoing postoperative treatment for Stage III colon

Updated on:December 26,2023

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on: December 30,2023

Discovery of drug candidate to potentially tackle ER-positive breast cancer

byMonash UniversityCredit:Cell Chemical Biology(2023). DOI: 10.1016/j.chembiol.2023.07.005An international team of researchers, led by Pfizer in collaboration with Monash University

Updated on:December 30,2023

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed

Updated on: December 22,2023

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed

Updated on:December 22,2023

Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic

Updated on: January 08,2024

Why people with breast cancer should ask their health care team about clinical trials

by Deb Balzer,Mayo ClinicCredit: Mayo ClinicTreatments for breast cancer have improved over the years, but much research still needs to be done.That's why Dr. Saranya Chumsri, a Mayo Clinic

Updated on:January 08,2024